免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA PMA

假肢,二尖瓣,经皮输送

PMA编号:P240042 · 2026-08-31

决定日期2026-08-31
PMA 编号P240042
产品代码NPU
设备分类第3类
医疗专科U
咨询委员会CV 请注意,由于原文未提供具体内容,以下是一个示例翻译: --- 产品名称:[产品名称] 公司名称:[公司名称] FDA批准号:[FDA批准号] 510(k)申请号:[510(k)申请号] PMA申请号:[PMA申请号] 临床试验注册号:[NCT] PubMed ID:[PMID] 产品标识符:[标识符] 产品URL:[URL] --- 请将上述示例中的[产品名称]、[公司名称]、[FDA批准号]等占位符替换为实际内容。

器械摘要

Prosthesis, mitral valve, percutaneously delivered is the device name listed in this FDA 510(k) record. The listed applicant is ABBOTT MEDICAL. It received FDA 510(k) clearance on 2026-08-31. The device is classified under product code NPU. It was reviewed by the CV advisory panel.

常见问题

What is the Prosthesis, mitral valve, percutaneously delivered?

Prosthesis, mitral valve, percutaneously delivered is a medical device that received FDA 510(k) clearance on 2026-08-31. The listed applicant is ABBOTT MEDICAL.

When did Prosthesis, mitral valve, percutaneously delivered receive FDA 510(k) clearance?

The clearance date for Prosthesis, mitral valve, percutaneously delivered can be found in the official FDA records.

谁是被列出的用于人工心脏瓣膜、二尖瓣、经皮输送的申请者?

The FDA 510(k) record lists ABBOTT MEDICAL as the applicant. This does not by itself establish the device manufacturer.

什么是用于经皮植入的瓣膜置换术的FDA产品代码?

FDA产品代码为人工心脏瓣膜、经皮植入的为NPU。

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑